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The pathophysiology of levodopa-induced dyskinesias (LID) in Parkinson’s disease is not well understood.
We have recorded local field potentials (LFP) from macroelectrodes implanted in the subthalamic nucleus
(STN) of 14 patients with Parkinson’s disease following surgical treatment with deep brain stimulation. Patients
were studied in the ‘Off ’ medication state and in the ‘On’ motor state after administration of levodopa–
carbidopa (po) or apomorphine (sc) that elicited dyskinesias in 11 patients. The logarithm of the power
spectrum of the LFP in selected frequency bands (4–10, 11–30 and 60–80 Hz) was compared between the
‘Off ’ and ‘On’ medication states. A peak in the 11–30 Hz band was recorded in the ‘Off ’ medication state
and reduced by 45.2% (P < 0.001) in the ‘On’ state. The ‘On’ was also associated with an increment of 77. 6%
(P < 0.001) in the 4–10 Hz band in all patients who showed dyskinesias and of 17.8% (P < 0.001) in the 60–80 Hz
band in the majority of patients. When dyskinesias were only present in one limb (n = 2), the 4–10 Hz peak was
only recorded in the contralateral STN. These findings suggest that the 4–10Hz oscillation is associatedwith the
expression of LID in Parkinson’s disease.
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Introduction
Levodopa-induced dyskinesias (LID) are observed in the
majority of patients with Parkinson’s disease who have
been treated for 5–10 years with levodopa (Schrag and
Quinn, 2000). LID may become highly disabling in
Parkinson’s disease. They are one of the primary limita-
tions to the therapeutic efficacy of levodopa and also a
principal motive for recommending surgical treatment
(Fahn, 2000; Lang, 2000). LID can be divided into two
main types according to the pattern of presentation
(Muenter and Tyce, 1971; Luquin et al., 1992; Obeso et al.,
2004): (i) choreic and dystonic movements during the
period of peak levodopa plasma levels and clinical benefit
(‘On’ dyskinesia), (ii) repetitive movements, usually of the
legs, that occur at the beginning and end of the levodopa
effect [diphasic dyskinesias or dystonia–improvement–
dystonia (DID)] and coincide with parkinsonism in other
body parts.
Recording of single unit neuronal activity in animal
models and in patients during surgery has established that
LID are physiologically characterized by a decreased firing
frequency and abnormal firing patterns in the subthalamic
nucleus (STN) and globus pallidus pars interna (GPi)
(Hutchison et al., 1998; Merello et al., 1999; Papa et al.,
1999; Lozano et al., 2000; Vitek and Giroux, 2000; Levy
et al., 2001; Stefani et al., 2002). These findings support the
model of basal ganglia pathophysiology that has fostered the
current resurgence of functional neurosurgery for Parkinson’s
disease and other movement disorders. However, a number of
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paradoxes and unexplained observations have emerged over
the years (Marsden and Obeso, 1994; Obeso et al., 2000). The
most outstanding of these is that pallidotomy in patients with
Parkinson’s disease who suffer from LID drastically abolishes
the involuntary movements to the extent that higher doses
of levodopa are tolerated while simultaneously improving
parkinsonian features (Lang, 2000). This is at odds with
the model, which maintains that the lesion (plus increased
levodopa intake) should further reduce neuronal activity in
the output nuclei of the basal ganglia and, as such, it should
fall more deeply into the hypoactive, dyskinetic range (Lozano
et al., 2000; Obeso et al., 2000; Vitek and Giroux, 2000).
In the last few years it has been recognized that in addition
to the firing rate the functional state of the basal ganglia may
also be characterized by changes in oscillatory neuronal activ-
ity or rhythms (Bevan et al., 2002; Heimer et al., 2002). Thus,
recordings from macroelectrodes implanted in the STN or
GPi for deep brain stimulation (DBS) have shown that in the
‘Off ’ parkinsonian state there is a predominant peak in the
11–30 Hz (beta band). Moreover, when patients are treated
with dopaminergic (DA) drugs, this beta rhythm is drastically
attenuated and activity in the 60–80 Hz gamma band
predominates (Brown et al., 2001; Levy et al., 2001;
Williams et al., 2002; Silberstein et al., 2003). In monkeys
with MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)
induced parkinsonism and patients with Parkinson’s disease,
beta oscillatory activity in the STN and GPi has also been
documented by microrecording (Wichmann et al., 1994;
Hutchison et al., 1998; Heimer et al., 2002; Brown, 2003).
Thus, it has been suggested that rather than modifications
of firing rate alone considering the changes in the oscillatory
activity could provide a more comprehensive picture of what
happens in the basal ganglia under different states of DA
activation (Brown, 2003). Indeed, this may perhaps help in
understanding some of the paradoxes of the basal ganglia
model (Marsden and Obeso, 1994; Brown, 2003). Here, we
have recorded local field potentials (LFP) from the STN of
patients with Parkinson’s disease treated with DBS and found
a significant correlation between the appearance of a peak at a
slow band frequency (4–10 Hz) and the presence of LID.
Patients and methods
Patients
Fourteen patients with a mean age of 55 years (41–69) and disease
duration of 10.5 years (7–15) were studied. Their clinical features
were typical of those currently considered candidates for treatment
with DBS of the STN and they were similar to patients previously
studied by our group (Obeso et al., 2001; Rodriguez-Oroz et al.,
2005). The patients were not adequately controlled with available
pharmacological treatments and fulfilled the CAPSIT (Core Assess-
ment Program for Surgical Intervention Therapies) criteria for sur-
gical treatment with DBS. The mean daily levodopa dose equivalent
(100 mg of standard levodopa = 130 mg of controlled-released
levodopa = 10 mg bromocriptine = 1 mg pergolide = 1 mg
lisuride = 1.5 mg pramipexole = 5 mg ropinirole) was 1125 mg
(range 725–1760). The mean Unified Parkinson’s Disease Rating
Scale (UPDRS) part III (0–118) in the ‘Off ’ and ‘On’ motor state
was 58 (36–64) and 17 (9–22), respectively. Eleven out of the
14 patients displayed dyskinesias in response to chronic levodopa.
These 11 patients were recorded while showing dyskinesias and the
other 3 were studied in the absence of LID. The CAPIT (Core Assess-
ment Program for Intracerebral Transplantation) dyskinesia scale
was used for evaluation (Langston et al., 1992). This scale evaluates
the intensity and duration of dyskinesias from 0 (absent) to 5 (very
severe, continuous and generalized) and separately scores ‘Off ’
period dystonia, diphasic (DID) and ‘On’ dyskinesias. Accordingly,
moderate and severe dyskinesias are associated with scores between 3
and 5. At the time of the study, a marked benefit in the motor
response to oral levodopa plus carbidopa (250–325 mg; n = 12) or
subcutaneous administration of apomorphine (4.5 and 5 mg, n = 2)
was observed with a mean reduction of 73% in the UPDRS motor
score. The study was included in the Parkinson’s disease surgical
protocol at our centre; it was approved by the institutional ethics
committee and each patient gave written informed consent.
Surgical technique
The surgical procedure involved a standard stereotactic approach
as described previously (Guridi et al., 1999; Obeso et al., 2001).
Macroelectrodes (Model 3389, Medtronic Neurological Division,
Minneapolis, MN, USA) were bilaterally implanted into the STN
in a single operation. The STN was localized using a CT–MRI
fusion-based technique (Stereoplan Radionics, Burlington, MA,
USA) and through intraoperative microrecording (platinum–
iridium electrodes) and microstimulation, as performed routinely
by our group (Rodriguez-Oroz et al., 2001). Emphasis was placed on
defining the dorsolateral region of the STN, which corresponds to the
motor segment of the nucleus (Rodrı´guez-Oroz et al., 2001). To
achieve this, a mean of 3.1 recording tracks were required per nucleus
and patient. Intraoperative fluoroscopy was used to monitor the
position of the macroelectrode during the implantation phase.
The most ventral contact of the DBS electrode was positioned to
match the end of the STN as estimated by microrecording. Definitive
placement of the macroelectrode was assessed by MRI 1–3 days after
surgery. In most instances the electrode was positioned within the
motor region of the STN on the basis of the findings obtained by
microrecording (Rodriguez-Oroz et al., 2001).
LFP recordings and pharmacological response
Recording sessions were conducted 2–4 days after surgery, having
ensured that the patients’ general state was satisfactory, their atten-
tion was normal and they could collaborate appropriately. The LFP
from the STN were recorded from the implanted macroelectrodes
through the external connection. The electrode (Medtronic 3389)
has a total length of 7.5 mm and contains four platinum–iridium
cylindrical contacts of 1.27 mm diameter, 1.5 mm length and with a
centre-to-centre separation of 2 mm. The four adjacent contacts were
labelled as 0, 1, 2 and 3 starting at the most caudal site. The contacts
were arranged in a bipolar montage for recording: 0–1, 1–2, 2–3. EEG
activity was also recorded via Ag–AgCl electrodes placed at FC3-FC4-
C3-C4-Cz in reference to linked earlobes (A1–A2). Electromyogra-
phy (EMG) signals were recorded with bipolar disposable surface
electrodes (Neuroline) placed on the limb muscles where tremor or
dyskinesias had been clinically detected. The motor state was care-
fully and continuously monitored during the study in order to detect
possible changes in any body segment. Particular attention was paid
to the presence of dyskinesias, even when of minor amplitude. STN
activity was amplified 100 000-fold and filtered at 0.3–100 Hz
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(Digitimer D-150, Cambridge, UK) before being digitized at 200 Hz
by an analogical/digital converter connected to a PC (CED—
Cambridge Electronic Design 1401 plus, Cambridge, UK). The
EEG activity was amplified 20 000-fold, filtered at 0.3–100 Hz (Bio-
logic, USA) and digitized at 200 Hz using the same A/D converter.
The acquisition and offline analysis of all signals was performed using
the Spike 2 software (Cambridge Electronic Design).
All sessions took place in the morning with patients in the ‘Off’
motor state after overnight withdrawal of antiparkinsonian medica-
tion. The ‘On’ motor state was subsequently achieved by oral admin-
istration of levodopa (50% over and above the usual morning dose).
In two patients who had a delayed onset response to levodopa, a
bolus of apomorphine (4, 5 and 5 mg, s.c.) was given to induce the
‘On’ response. The efficient dose of apomorphine for either patient
had been estimated before surgery and was shown to reliably induce a
motor response similar to that achieved by levodopa.
Subjects were seated in an armchair and recordings were continu-
ously registered at rest while in the ‘Off ’ motor state (five patients
exhibited tremor at rest), ‘intermediate’ state (i.e. diphasic dyskine-
sias and beginning of the motor improvement) and in the best motor
response (‘On’ motor state). The mean length of the recordings was
88.5 min (60–120). Segments with artefacts were discarded for offline
analysis. Thus, a mean of 4.6 (range = 3–11) artefact-free segments of
STN activity, lasting between 240 and 1216 s, were analysed for each
patient. At least one segment corresponding to each of the ‘Off’,
‘intermediate’ and ‘On’ states was obtained from every patient.
During the study, four patients had diphasic dyskinesias that were
moderate to severe (mean score = 3.5) and 11 patients showed
choreic dyskinesias in the ‘On’ motor state. These were present
over most of the ‘On’ period and were fairly severe (mean dyskinesia
score = 3.8).
Data analysis
The bipolar channels used for the analysis were always those with
either the highest power value or the greatest power change. First, a
fast Fourier transformation (FFT) was performed on non-
overlapping sections of the same length (256 points, 1.28 Hz/bin
resolution) from each segment of STN activity using the Spike 2
software package. The results were averaged across sections and the
resulting average (0–100 Hz) was presented as a power histogram
(squared volt/frequency). The number of averaged sections per seg-
ment was 761–3765 (mean = 1672) and distinctive frequency peaks
from each segment-average were identified. These peaks were defined
as more than two contiguous bins (2.5 Hz wide) with an absolute
power two times greater than the two adjacent bins immediately
preceding and following (two either side) the selected frequency
(Silberstein et al., 2003). As a second approach, the absolute
power of the LFP within selected frequency bands (4–10, 11–30
and 60–80 Hz) was compared between the ‘Off’ and ‘On’ motor
state in all subjects. These bands were chosen according to our initial
experiences in recording LFP in Parkinson’s disease patients (Obeso
et al., 2004), as well as from published data, indicating that these
activities best differentiate between different motor states and may be
functionally significant (Brown et al., 2001; Williams et al., 2002;
Silberstein et al., 2003; Priori et al., 2004). For the purpose of this
study we assessed the entire range of the beta band as a whole,
although its subdivision into two components (Priori et al., 2004)
might be useful in some instances. In individual subjects, the absolute
power was applied to correlate specific changes (i.e. the 4–10 Hz
band) in STN activity and dyskinesias during a given period (i.e.
DID) or when restricted to a given body part.
The mean logarithmic power was calculated for the whole patient
population and compared for each band during the ‘Off’ and ‘On’
motor states. The values of the percentage reduction or increase were
calculated by comparing the mean power during 3 min periods in
the ‘On’ and ‘Off’ states. The artefact-free periods were selected from
the last recorded segment before L-dopa intake (‘Off’ state) and the
segment coinciding with the best clinical effect (‘On’).
All artefact-free segments of STN activity representing an
‘Off–On’ cycle from each patient (mean = 4.7 segments per patient)
were merged into a single file, resulting in traces of 975–4820 s
in duration (mean = 2141). A custom program allowed us to select
the frequency band to analyse (4–10, 11–30, 60–80 Hz) and to cal-
culate the power of the selected frequency band (by means of an FFT
along the ‘Off–On’ cycle in 20 s epochs. Statistical analysis was
performed using the SPSS software package for Windows (version
9; Chicago, IL, USA). A matched-pairs t-test was applied to compare
the difference in logarithmic power between the ‘Off’ and ‘On’ motor
states in the presence or absence of dyskinesias.
Results
Modification of oscillatory activity
according to the DA state
Fourteen recording sessions were obtained from 28 STN. In
the ‘Off ’ motor state, a peak was found in the 11–30 Hz band
in all patients (Fig. 1A) while in the patients who had severe
tremor at rest the predominant peak coincided with the
tremor frequency (4–6 Hz). The ‘On’ motor state was char-
acterized by two distinctive peaks that were registered in the
60–80 Hz and 4–10 Hz bands (Fig. 1A). In most instances, the
transition from the ‘Off ’ to the ‘On’ motor state occurred
gradually over several minutes (Fig. 1B). This transition was
characterized by a reduction of 45.2% (P < 0.001) in the
logarithmic power of the 11–30 Hz band and an increment
of 17.8% (P < 0.001) and 77.6% (P < 0.001) in the 60–80 and
4–10 Hz bands, respectively (Fig. 1C). In three patients, no
clear peak in the 60–80 Hz band was recorded during the ‘On’
state. Furthermore, in another three patients, who did not
develop dyskinesias, there was no increment in the 4–10 Hz
band (see below).
Oscillatory activity and LID
A significant increment (77.6%) in the 4–10 Hz band was
observed in all patients who developed dyskinesias in response
to medication. The increment in the logarithmic power of the
4–10 Hz band observed was similar when the periods of
diphasic versus ‘On’ dyskinesias were compared. Patients
who did not exhibit dyskinesias in response to levodopa or
apomorphine did not show any such increment, and this
difference between groups was statistically significant (P <
0.05) (Fig. 2A). Moreover, in one patient with DID and an
excellent ‘On’ response without dyskinesias, the increment in
the 4–10 Hz band was only recorded before the ‘On’ motor
state and the associated increment in the 60–80 Hz band
(Fig. 2B). In three patients who displayed both DID and
‘On’ dyskinesias, the slow band activity increased with the
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onset of DID and this increase lasted for the whole period of
‘On’ dyskinesias.
Specificity of the findings
Topographically, the changes in LFP were specifically distrib-
uted within the STN (Fig. 3). In the majority of studies the
maximal reduction in the 11–30 Hz band and the increment
in the 60–80 Hz band predominantly took place at the level
of the second more dorsal contact (Fig. 3), which is usually
the one within the motor region of the STN. However, the
increment in activity of the 4–10 Hz band was not so clearly
confined to the dorsal region, and 45% of recordings showed
that the major change in the 4–10 Hz band occurred in the
most ventral recording sites.
In most patients (n = 9) LID were bilateral. In two patients
with asymmetrical LID the association between the presence
of dyskinesias in specific limbs and the appearance of a peak in
the 4–10 Hz band could be studied. An absolute increment in
the 4–10 Hz band in the right STN (+85%) coupled with a
slight reduction (8%) in the left STN was observed in one
patient who developed dyskinesias only in the left lower limb
during the ‘On’ state. In this subject, the typical increment in
the 60–80 Hz band occurred bilaterally, in accordance with
the general motor improvement in the ‘On’ motor state
(Fig. 4). A bout of choreic dyskinesias exclusively in the
right hemi-body that lasted for some 10 min was experienced
by another subject before the dyskinesias became generalized
and affected the left limbs as well. Accordingly, the increment
in the 4–10 Hz band occurred first in the left STN and only
appeared in the right STN when the dyskinesias appeared in
the left hemi-body (Fig. 5). No attempt was made to establish
whether or not the changes in the 4–10 Hz band appeared
before or after the dyskinesias were observed.
Fig. 1 Evolution of the LFPs recorded from the STN in one patient. Autospectra of the predominant peaks for the 11–30, 4–10 and
60–80 Hz bands (A, left STN) and its evolution from the ‘Off’ motor state to the beginning of the motor improvement (intermediate)
and the ‘On’ state with dyskinesias (B, right STN). The discontinuous traces and numbers at the bottom indicate the period of valid
recording in minutes. (C) Relative magnitude of the change in the logarithmic power in the three bands from the ‘Off’ to the ‘On’
motor states and the number of recorded subthalamic nuclei (in brackets) where this occurred.
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Fig. 3 Evolution of the LFP autospectra throughout the ‘Off–On’ cycle and the predominant site of recording with respect to the three
bipolar contacts in the STN. In the ‘Off’ motor state (left) in a patient with tremor (A), there is a predominant peak at around 5 Hz while in a
patient without tremor (B) there is only a peak at around 11–12 Hz that is maximal at the second-most dorsal STN contact. In the
‘On’ + dyskinesias motor state (right), the same patient shown in B exhibited a 4–10 Hz peak predominantly at the ventral recording site
(C) and a 60–80 Hz peak at all three sites although the middle contact predominated (D).
Fig. 2 (A) Magnitude of the increment in the 4–10 Hz band in patients with (n = 11) and without dyskinesias (n = 3) at the time of the study.
(B) Comparative evolution of the autospectra for the >60 Hz and the 4–10 Hz bands in a patient who had tremor at rest, developed diphasic
dyskinesias (DID) but had no dyskinesias during the ‘On’ motor state. The discontinuous traces and numbers at the bottom indicate the
period of valid recording in minutes.
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Slow (4–10 Hz) oscillatory activity and the
effect of involuntary movements
The relationship between the 4–10 Hz band and dyskinesias
could be secondary to the somatosensory afferent activity
associated with the movement and, therefore, it could be
understood simply as the consequence of the dyskinesias.
We have examined this issue in three subjects whose 4–10
and >60 Hz spectra could be analysed and separated into brief
periods with or without dyskinesias (Fig. 6A). The mean
duration of each interval analysed was 194 s for segments
with dyskinesia and 208 s for segments without these move-
ments. The periods that were free of dyskinesias were sepa-
rated and analysed independently from the ones with
dyskinesias. The power spectrum was analysed every 2 s
and the EEG (Cz electrode), EMG and each pair contact of
STN electrodes were averaged. The differences between ‘Off’
and ‘On’ periods with and without dyskinesias were calculated
using factorial ANOVA (analysis of variance) without inter-
actions with the post hoc test for multiple comparisons. There
was a significant increment in the 4–10 Hz band (P < 0.001)
and the 60–80 Hz band (P < 0.001) in the ‘On’ motor state
when compared with the ‘Off’ motor state (Fig. 6B and C).
However, no significant difference (P = 0.5) in the power
of the 4–10 Hz (P = 0.5) (Fig. 6B) and the 60–80 Hz band
(P = 0.4) (Fig. 6C) was detected when the recording fragments
with and without dyskinesias were analysed separately (Fig. 6).
The possibility that the changes induced in the frequency
spectrum were artefacts of movement (i.e. due to dyskinesia)
appeared less likely by examining the scalp EEG. There was no
significant change in the 4–10 Hz (P = 0.3) bands during the
recording intervals in the ‘On’ state whether or not dyskine-
sias were observed (Fig. 6E). Identical results to the findings
shown in Fig. 6 for one of the patients were corroborated in
another two patients. These results indicate that the modifi-
cations in the 4–10 Hz range are not due to the movements
per se but are primarily associated with the physiological
mechanisms causing dyskinesias.
Discussion
We have found that dyskinesias (both diphasic and ‘On’
dyskinesias) induced by DA drugs in patients with
Parkinson’s disease are associated with an increment in
the 4–10 Hz band. Our patient population exhibited severe
µV2
µV2
Fig. 4 Example of the LFP recorded from a patient with ‘On’ period dyskinesias in the left leg only. The 4–10 Hz band is only detected
in the right STN (A) while the 60–80 Hz increased during the ‘On’ phase in both STN nuclei (A and B). This patient had a tremor at rest
in the upper right limb explaining the presence of theta band activity in the left STN (B) and its attenuation after levodopa. Numbers
at the bottom indicate the period of valid recording in minutes for each motor state.
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LID both pre- and postoperatively. Thus, we were able to
study LID in a relatively large number of patients after
surgery when, in general, dyskinesias are attenuated in the
postoperative period (Silberstein et al., 2005). These findings
further extend previous studies defining a clear correlation
between the different motor states and the predominant
oscillatory activity in the STN in Parkinson’s disease
(Brown et al., 2001; Priori et al., 2004; Fogelson et al.,
2005).
Methodological aspects
While the presence of slow oscillatory activity raises concerns
about recording movement-induced artefacts, we believe that
our data argue against such a possibility. First, electromyo-
graphic and kinematic studies have shown that the frequency
of LID is typically lower than the 4–10 Hz peak recorded from
the STN and scalp in our patients (Luquin et al., 1992;
Marconi et al., 1994; Manson et al., 2000). Secondly,
movement-free segments of recordings showed exactly the
same 4–10 Hz peak. Thirdly, we found that the topographical
distribution of the changes in the spectrum recorded in the
STN maintained a fairly clear relationship with the affected
part of the body. Thus, the 11–30 Hz activity during the ‘Off’
state and the 60–80 Hz band during the ‘On’ state predomi-
nated bilaterally in the most dorsal region of the nucleus.
In contrast, the slow 4–10 Hz band was found only in the
contralateral STN when the dyskinesias were asymmetrically
distributed. All these observations make it unlikely that the
slow activity recorded during LID was due to a movement-
induced artefact or a bias in the analysis.
Another potential concern when interpreting the data is the
actual location of the recording electrodes. Admittedly, cur-
rent imaging techniques (i.e. magnetic resonance) do not
allow the exact location of the DBS electrode to be precisely
defined. However, we placed the DBS electrode at coordinates
that coincide with motor-related activity as assessed by micro-
recording. Moreover, a recent study has shown a close corre-
lation between neuronal discharges and LFPs recorded from
the STN (Kuhn et al., 2005). In addition, experience with the
recording of LFPs in the STN has shown that the contact sites
outside the nucleus show a different baseline activity and do
Fig. 5 Example of a patient with asymmetrical dyskinesias that first began in the right limbs, becoming bilateral several minutes later.
The increment in the 4–10 Hz band in the left STN (A) precedes that in the right STN (B). The discontinuous traces and numbers at
the bottom indicate the period of valid recording in minutes for each motor state.
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not exhibit the characteristic modulation of beta activity when
performing a task (Kuhn et al., 2004; Alegre et al., 2005;
Williams et al., 2005). We did not perform a coherence ana-
lysis between STN oscillatory activity and EMG signals during
LID mainly because of the inherent difficulty associated with
the variable and irregular pattern of muscle activation that
characterizes choreic movements. Future studies should
include such an analysis to ascertain whether similar activity
can be recorded during voluntary movement that resembles
limb dyskinesias, and to examine possible task-related modi-
fications of 4–10 Hz activity.
Finally, it may be worth mentioning that in this study
we only included patients who showed a recognizable and
well-defined pattern in their motor response to levodopa
(or apomorphine). As such, the ‘Off’ state, as well as the
beginning of the effect with diphasic dyskinesias, the ‘On’
state and the ‘On’ with ‘peak dose’ dyskinesias were clearly
defined and evaluated. This approach has been routinely
employed by our group to assess levodopa-related motor
complications in Parkinson’s disease (Vaamonde et al.,
1991; Luquin et al., 1992).
Origin and significance of the changes in
oscillatory activity
While a possible association between LID and a 4–10 Hz peak
in the basal ganglia has been noted in earlier studies, the
details of such an association have not yet been described.
Slow oscillatory activity (3–6 Hz) in the basal ganglia (STN,
GPi and globus pallidum pars externa) is closely associated
with limb tremor in both MPTP monkeys and Parkinson’s
disease patients in the ‘Off ’ state (Rodriguez et al., 1998; Raz
et al., 2000; Levy et al., 2000, 2002; Priori et al., 2004). The
increment in the 4–10 Hz band when passing from the ‘Off ’ to
the ‘On’ motor state may represent a specific association with
the presence of involuntary movements (Silberstein et al.,
2003). Two recent reports are in keeping with our results.
Foffani et al. (2005) recorded LFPs simultaneously from the
STN and GPi in one patient with Parkinson’s disease and
found increased coherence between both nuclei at low fre-
quencies (<10 Hz) contralateral to the side of the body where
LID were observed. Silberstein et al. (2005) recorded the LFPs
from the GPi in two patients with mild LID (clinical details
were not given) and found a significant inverse correlation
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Fig. 6 Analysis of data from a patient with diphasic dyskinesias in the right leg. (A) The top trace is an example of electromyographic (EMG)
trace recorded from the right tibialis anterior muscle. Periods that were free of dyskinesias were separated and analysed independently.
The bottom graphs represent the LFP 4–10 Hz autospectra from the left STN (B), >60 Hz autospectra from the left STN (C), the
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between activity in the 13–30 Hz band and the presence of
dyskinesias. We observed that by and large the 4–10 Hz
activity in the STN was associated with dyskinesias. In two
patients with asymmetrical LID, the 4–10 Hz activity was
recorded only on the contralateral STN. Thus, it appears
that the 4–10 Hz peak may represent a specific neuronal
pattern associated with the dyskinesias elicited by DA
drugs. This hypothesis is further supported by similar
findings reported in the rat 6-OHDA model where the
number of bursting cells increased and a significant correl-
ation between single cell discharges and oscillatory activity in
the theta band was found only in dyskinetic animals
(Meissner et al., 2006). Indeed, Silberstein et al. (2003)
have suggested that the 4–10 Hz peak associated with LID
in Parkinson’s disease and in patients with torsion dystonia
may be due to increased bursting discharges, a physiological
feature that has also been encountered in animal models and
patients exhibiting LID (Lozano et al., 2000; Boraud et al.,
2001; Levy et al., 2001), hemichoreaballism (Suarez et al.
1997) and dystonia (Gernert et al., 1998; Lenz et al., 1998).
Whether or not bursting discharges and slow oscillations may
be equated and represent a common functional alteration of
the basal ganglia for most dyskinetic disorders (Silberstein
et al., 2003) cannot be resolved with the currently available
information.
Relevance of the slow 4–10 Hz oscillation
in the pathophysiology of LID in
Parkinson’s disease
In the ‘On’ dyskinetic state, neuronal activity in the STN and
GPi is characterized by a reduction in the mean firing fre-
quency, increased bursting and increased variability in the
pauses between discharges (Boraud et al., 2001). Together,
this gives rise to a different pattern of neuronal activity in the
output of the basal ganglia (Hutchinson et al., 1998; Merello
et al., 1999; Papa et al., 1999; Lozano et al., 2000; Vitek and
Giroux, 2000; Levy et al., 2001).
The 4–10 Hz oscillatory activity could represent a specific
signal that conveys a code to the thalamocortical motor
projection to release involuntarily fragments of movement
(i.e. dyskinesias). This possibility is supported by the observa-
tion that 5-Hz stimulation of the STN induces choreiform
movements of the contralateral upper limb (Liu et al., 2002).
Alternatively, it could represent a functional state, setting a
level of excitability that allows the occurrence of involuntary
movement. The presence of a similar 4–10 Hz rhythm in the
GPi of patients with torsion dystonia (Silberstein et al., 2003)
would favour a non-specific dysregulation of movement con-
trol. This interpretation would more easily fit with the idea
that the same type of surgery (i.e. pallidotomy or DBS of the
GPi) improves both LID and dystonia by eliminating or inter-
fering with the slow oscillatory activity discussed here. A
comprehensive view would be that the 4–10 Hz and the
gamma rhythms, albeit recorded simultaneously, are in fact
the result of synchronization of distinct neuronal populations
within the STN. In keeping with this, studies measuring glu-
cose consumption in MPTP monkeys found a significant
increment in the ventral region of the STN in animals that
developed LID (Mitchell et al., 1992; Guigoni et al., 2005). It is
likely that corticobasal ganglia activity related to LID differs
from the one sustaining normal movement control. Accord-
ingly, the predominant physiological rhythms recorded in the
basal ganglia may also be different.
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